Published: 3 September 2020
Committees
Agenda for the 183RD meeting of the Medicines Adverse Reactions Committee to be held on Thursday 10 SEPTEMBER 2020, at 9 am
1. |
MATTERS OF ADMINISTRATION |
1.1 |
Welcome and apologies |
1.2 |
Minutes and recommendations of the 182nd MARC meeting |
1.3 |
Declarations of potential conflicts of interest |
2. |
MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE |
2.1 |
CARM quarterly report |
3. |
PHARMACOVIGILANCE REPORTS |
3.1 |
Matters referred to the MARC by Medsafe |
3.1.1 Consideration of Cathejell (lignocaine) 2% gel under section 36 of the Medicines Act 1981 | |
3.2 |
Matters referred to the MARC by Medsafe |
3.2.1 Macrolides in pregnancy | |
3.2.2 Domperidone: benefit-risk review of use in children under 12 years old | |
4. |
MEDSAFE PHARMACOVIGILANCE ACTIVITIES |
4.1 |
Report on standing agenda items |
4.2 |
Medsafe pharmacovigilance activities |
4.3 |
Prescriber Update |
4.4 |
Quarterly summary of recent safety communications |
5. |
OTHER BUSINESS |
Please note that this is a shortened agenda as the meeting needs to be held via videoconference.